DOCSLIB.ORG

Kinase Signal Pathway Ras-Independent Mitogen-Activated Protein Direct Tumor Lysis by NK Cells Uses A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Kinase Signal Pathway Ras-Independent Mitogen-Activated Protein Direct Tumor Lysis by NK Cells Uses A Direct Tumor Lysis by NK Cells Uses a Ras-Independent Mitogen-Activated Protein Kinase Signal Pathway This information is current as Sheng Wei, Danielle L. Gilvary, Brian C. Corliss, Said Sebti, of September 28, 2021. Jiazhi Sun, David B. Straus, Paul J. Leibson, Joseph A. Trapani, Andrew D. Hamilton, Michael J. Weber and Julie Y. Djeu J Immunol 2000; 165:3811-3819; ; doi: 10.4049/jimmunol.165.7.3811 Downloaded from http://www.jimmunol.org/content/165/7/3811 References This article cites 55 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/165/7/3811.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Direct Tumor Lysis by NK Cells Uses a Ras-Independent Mitogen-Activated Protein Kinase Signal Pathway 1 Sheng Wei,*‡ Danielle L. Gilvary,*‡ Brian C. Corliss,* Said Sebti,†‡ Jiazhi Sun,†‡ David B. Straus,§ Paul J. Leibson,¶ Joseph A. Trapani,ʈ Andrew D. Hamilton,** Michael J. Weber,†† and Julie Y. Djeu2*‡ Destruction of tumor cells is a key function of lymphocytes, but the molecular processes driving it are unclear. Analysis of signal molecules indicated that mitogen-activated protein kinase (MAPK)/extracellular regulated kinase 2 critically controlled lytic function in human NK cells. We now have evidence to indicate that target ligation triggers a Ras-independent MAPK pathway that is required for lysis of the ligated tumor cell. Target engagement caused NK cells to rapidly activate MAPK within 5 min, and PD098059 effectively blocked both MAPK activation and tumoricidal function in NK cells. Target engagement also rapidly activated Ras, detected as active Ras-GTP bound to GST-Raf-RBD, a GST fusion protein linked to the Raf protein fragment Downloaded from containing the Ras-GTP binding domain. However, Ras inactivation by pharmacological disruption with the farnesyl transferase inhibitor, FTI-277, had no adverse effect on the ability of NK cells to lyse tumor cells or to express MAPK activation upon target conjugation. Notably, MAPK inactivation with PD098059, but not Ras inactivation with FTI-277, could interfere with perforin and granzyme B polarization within NK cells toward the contacted target cell. Using vaccinia delivery of N17 Ras into NK cells, we demonstrated that IL-2 activated a Ras-dependent MAPK pathway, while target ligation used a Ras-independent MAPK pathway http://www.jimmunol.org/ to trigger lysis in NK cells. The Journal of Immunology, 2000, 165: 3811–3819. he mitogen-activated protein kinases (MAPK)3 integrate (8–10). Activation of ERK by growth factor receptor triggering multiple intracellular signals within a cell responding to follows a highly conserved set of molecular events, connected to T different external stimuli. Of the MAPK kinase family, upstream signals associated with the receptor. Association of the which includes c-Jun N-terminal kinase/stress-activated protein ki- GRB-2/SOS complex to the receptor recruits Ras to the plasma nase, p38/MAPKAP kinase 2 reactivity kinase (RK), and MAPK/ membrane, resulting in Raf-1 binding to activated GTP-bound extracellular regulated kinase (ERK), the last subgroup is the most Ras. Subsequent activation of Raf-1 leads to its phosphorylation of extensively investigated, particularly in events associated with MAPK/ERK kinase 1 (MEK-1), which, in turn, becomes activated as by guest on September 28, 2021 growth factor receptors and G protein-coupled receptors (1, 2). a dual kinase, with the ability to phosphorylate the TEY motif ERKs are differentiated from the other MAPKs by their conserved in ERK. TEY motif, which becomes dually phosphorylated at the Tyr and ERK has largely been considered a growth- and differentiation- Thr sites upon activation. They play a critical role in gene expres- related signal molecule, involved in transcriptional control of crit- sion related to cell growth and differentiation. They have the abil- ical genes essential for cell proliferation/maturation, but it is likely ity to activate nuclear transcription factors, including Elk-1, c-Jun, that it plays a crucial role in other cellular events. For example, c-Myc, NF-IL-6, and TAL1 (3–7), as well as cytoplasmic sub- ERK has recently been reported to activate superoxide release (11) rsk strates, such as phospholipase A2, pp90 , and RNA polymerase and modulate cell-cell or cell-matrix interactions (12, 13). Cell secretion may also be driven by ERK (14). We therefore undertook the task of investigating whether ERK was important in lympho- *Immunology Program and †Drug Discovery Program, and ‡H. Lee Moffitt Cancer Center, Department of Biochemistry and Molecular Biology, University of South cyte function against tumor cells. Target ligation can direct two Florida College of Medicine, Tampa, FL 33612; §Department of Pathology, Uni- separate and distinct functions in lymphocytes, dictated by the in- versity of Chicago, Chicago, IL 60637; ¶Department of Immunology, Mayo Clinic, Rochester, MN 55905; ʈCellular Cytotoxicity Laboratory, Austin Research Institute, duction and effector phases. In the induction phase, the event trig- Heidelberg, Victoria, Australia; **Department of Chemistry, Yale University, New gered by TCR coupling to its Ag on quiescent T cells leads to †† Haven, CT 06511; and Department of Microbiology, University of Virginia, Char- signals that up-regulate genes associated with cytokine induction lottesville, VA 22908 and cell proliferation, resulting in clonal expansion and functional Received for publication May 30, 2000. Accepted for publication July 14, 2000. activation (15). Upon re-encounter of the Ag, activated T cells The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance express lytic function in the effector phase. The signal pathways with 18 U.S.C. Section 1734 solely to indicate this fact. coupled to the TCR during the initial activation phase must differ 1 This work was supported by a grant from the U.S. Public Health Service (CA83146) from those during the effector phase, because different functions and by American Heart Association Grant AHA 970175. prevail. Research to date has focused on the induction phase, and 2 Address correspondence and reprint requests to Dr. Julie Y. Djeu, Immunology it is established that the TCR is coupled to nonreceptor tyrosine Program, H. Lee Moffitt Cancer Center, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612. E-mail address: djeu@moffitt.usf.edu kinases, Lck and Zap70 (15). These kinases, in turn, trigger down- stream events via calcium- and Ras-dependent pathways. Zap70 3 Abbreviations used in this paper: MAPK, mitogen-activated protein kinase; FTI, farnesyl transferase inhibitor; ERK, extracellular regulated kinase 2; LGL, large gran- can phosphorylate a membrane-bound adaptor protein, linker for ular lymphocyte; PLC, phospholipase C; RBD, Ras-GTP binding domain; PI 3-ki- activation of T cells (LAT), which subsequently binds phospho- nase, phosphoinositide 3-kinase; MEK-1, MAPK/ERK kinase 1; TRITC, tetrameth- ␥ ␥ ylrhodamine isothiocyanate; RK, MAPKAP kinase 2 reactivity kinase; GRB2, growth lipase C 1 (PLC 1) and growth factor receptor binding protein 2 factor receptor binding protein 2. (GRB2) (16, 17). Activation of PLC␥1 leads to inositol phosphate Copyright © 2000 by The American Association of Immunologists 0022-1767/00/$02.00 3812 RAS-INDEPENDENT MAPK REQUIRED FOR NK LYSIS and intracellular calcium mobilization, while formation of the containing 10% FCS with 2 mM L-glutamine, 100 U/ml penicillin, and 100 GRB2-SOS complex recruits Ras to the membrane, turning on the ␮g/ml streptomycin (30). Raf/MEK/MAPK pathway (18, 19). MAPK is known to activate Isolation of large granular lymphocytes (LGL) from peripheral several important transcription factors required for IL-2 and other blood cytokine gene induction (20). The involvement of Vav and 76-kDa SH2 domain leukocyte protein in T cell signal pathways has also NK cells were derived from LGL isolated from PBMC of normal volun- teers as previously described (4). After plastic adherence for1hat37°C been recently described, and the ability of 76-kDa SH2 domain and passage through nylon wool, the nonadherent mononuclear cells were leukocyte protein to bind Grb2 could provide another link to the placed on a four-step discontinuous Percoll gradient. The cells recovered Ras-dependent MAPK pathway (21, 22). from 42.5–45.0% Percoll usually contained 75–90% LGL, as assessed by Studies to date have thus documented that the conserved Ras/ Giemsa-stained morphology, and were used to test NK function. Raf/MEK/MAPK pathway is invoked by ligands binding to their Pharmacological inhibition of MAPK and Ras Ag receptors. This finding is expected, given that Ag recognition ϫ 6 leads to lymphocyte activation, resulting in gene expression related For MAPK inhibition, NK92 cells or fresh LGL (2.5 10 cells/ml) were incubated for2hat37°C with medium or serial dilutions of PD098059 to clonal expansion, a noted example of which is IL-2. However, (New England Biolabs, Beverly MA) or an equal amount of DMSO to once activated, T cells must express a separate and distinct func- dilute the highest concentration of inhibitor (31).
Load more

Recommended publications
  • Redox-Mediated Regulation of the Tyrosine Kinase Zap70
    Redox-mediated regulation of the tyrosine kinase Zap70 DISSERTATION zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) genehmigt durch die Fakultät für Naturwissenschaften der Otto-von-Guericke-Universität von M.Sc. Christoph Thurm geb. am 27.06.1988 in Borna Gutachter: apl. Prof. Dr. Luca Simeoni PD Dr. rer. nat. Marcus Lettau eingereicht am: 02.02.2018 verteidigt am: 06.06.2018 Eigenständigkeitserklärung I. Eigenständigkeitserklärung Christoph Thurm Halberstädter Straße 29 39112 Magdeburg Hiermit erkläre ich, dass ich die von mir eingereichte Dissertation zu dem Thema Redox-mediated regulation of the tyrosine kinase Zap70 selbständig verfasst, nicht schon als Dissertation verwendet habe und die benutzten Hilfsmittel und Quellen vollständig angegeben wurden. Weiterhin erkläre ich, dass ich weder diese noch eine andere Arbeit zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) an anderen Einrichtungen eingereicht habe. Magdeburg, den 02.02.2018 ____________________________________ M.Sc. Christoph Thurm II ACKNOWLEDGEMENTS II. Acknowledgements Firstly, I would like to express my sincere gratitude to my supervisor Prof. Dr. Luca Simeoni. His extraordinary support during my PhD thesis together with his motivation and knowledge enabled me to pursue my dream. I could not have imagined having a better mentor. Furthermore, I would like to thank Prof. Dr. Burkhart Schraven for giving me the opportunity to work in his institute. His support, ideas, and the lively discussions promoted me to develop as a scientist. Special thanks go also to the whole AG Simeoni/Schraven - Ines, Camilla, Matthias, and Andreas - for the help with experiments, the discussions, and the fun we had. This helped to sustain also the longest days.
    [Show full text]
  • Non-Redundant Dual Functions of the ZAP70 Catalytic and Scaffolding
    ical C lin as C e Isakov, J Clinic Case Reports 2012, 2:6 f R o l e DOI: 10.4172/2165-7920.1000e113 a p n o r r t u s o J Journal of Clinical Case Reports ISSN: 2165-7920 Editorial Open Access ZAP70-Related SCID: Non-Redundant Dual Functions of the ZAP70 Catalytic and Scaffolding Regions Noah Isakov* The Shraga Segal Department of Microbiology and Immunology, Faculty of Health Sciences and the Cancer Research Center, Ben Gurion University of the Negev, P.O.B. 653, Beer Sheva 84105, Israel Primary Severe Combined Immunodeficiency (SCID) is a form rearrangement of the actin cytoskeleton. These transient intracellular of heritable immunodeficiency, characterized by impaired adaptive signals permit the activation of selected transcription factors that immune responses [1]. It includes a group of genetic disorders promote the proliferation and differentiation of T cells. originated by defects in one of several different genes that are critical Analysis of the phosphorylation sites of ZAP-70 and their impact for T lymphocyte production and/or function and involve defects in B on the function of the molecule demonstrated that phosphorylation lymphocytes as a primary or secondary cause [2]. of Tyr319, Tyr492 and Tyr493 serves to regulate the ZAP70 catalytic The most common type of SCID is linked to the X chromosome activity [23-25]. However, in vivo activation of T cells results in ZAP70 (X-SCID), and therefore affects only males [3,4]. The X-SCID males phosphorylation on additional tyrosine residues [26,27] which may possess mutations in the interleukin-2 (IL-2) receptor gamma chain also function as putative docking sites for SH2-containing proteins.
    [Show full text]
  • C-MET) Prolongs the Survival of Chronic Lymphocytic Leukemic Cells Through STAT3 Phosphorylation: a Potential Role of Mesenchymal Cells in the Disease
    SUPPLEMENTARY APPENDIX An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease Paolo Giannoni,1 Silvia Scaglione,2 Rodolfo Quarto,1,3 Roberto Narcisi,3 Manuela Parodi,1 Enrico Balleari,4 Federica Barbieri,5 Alessandra Pattarozzi,5 Tullio Florio,5 Silvano Ferrini,6 †Giorgio Corte,7 and Daniela de Totero7 1Stem Cell Laboratory, Advanced Biotechnology Center, 16132, Genova; 2Dept. of Communication, Computer and System Sciences (D.I.S.T.), University of Genova, 16132, Genova; 3Dept. of Experimental Medicine (Di.Me.S.), University of Genova, Genova; 4Hematological Dept., San Martino Hospital, 16132, Genova; 5Pharmacology Laboratory, Dept. of Oncology, Biology and Genetics (D.O.Bi.G.), University of Genova, 16132, Genova; 6Immunological Therapies Laboratory and 7Gene Transfer Laboratory, National Institute for Cancer Research, 16132, Genova, Italy Citation: Giannoni P, Scaglione S, Quarto R, Narcisi R, Parodi M, Balleari E, Barbieri F, Pattarozzi A, Florio T, Ferrini S, Corte G, and de Totero D. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica 2011;96(7):1015- 1023. doi:10.3324/haematol.2010.029736 Online Supplementary Design and Methods ac.uk/microarray-as/ae/) and analyzed in silico with Bioconductor (open source Version 1.2.0; http://www.bioconductor.org/docs/faq/) Immunofluorescence analysis of cell surface antigen for background subtraction and normalization (series acces- expression on chronic lymphocytic leukemia cells sion numbers detailed in Online Supplementary Table S2).
    [Show full text]
  • A Chemical Proteomic Approach to Investigate Rab Prenylation in Living Systems
    A chemical proteomic approach to investigate Rab prenylation in living systems By Alexandra Fay Helen Berry A thesis submitted to Imperial College London in candidature for the degree of Doctor of Philosophy of Imperial College. Department of Chemistry Imperial College London Exhibition Road London SW7 2AZ August 2012 Declaration of Originality I, Alexandra Fay Helen Berry, hereby declare that this thesis, and all the work presented in it, is my own and that it has been generated by me as the result of my own original research, unless otherwise stated. 2 Abstract Protein prenylation is an important post-translational modification that occurs in all eukaryotes; defects in the prenylation machinery can lead to toxicity or pathogenesis. Prenylation is the modification of a protein with a farnesyl or geranylgeranyl isoprenoid, and it facilitates protein- membrane and protein-protein interactions. Proteins of the Ras superfamily of small GTPases are almost all prenylated and of these the Rab family of proteins forms the largest group. Rab proteins are geranylgeranylated with up to two geranylgeranyl groups by the enzyme Rab geranylgeranyltransferase (RGGT). Prenylation of Rabs allows them to locate to the correct intracellular membranes and carry out their roles in vesicle trafficking. Traditional methods for probing prenylation involve the use of tritiated geranylgeranyl pyrophosphate which is hazardous, has lengthy detection times, and is insufficiently sensitive. The work described in this thesis developed systems for labelling Rabs and other geranylgeranylated proteins using a technique known as tagging-by-substrate, enabling rapid analysis of defective Rab prenylation in cells and tissues. An azide analogue of the geranylgeranyl pyrophosphate substrate of RGGT (AzGGpp) was applied for in vitro prenylation of Rabs by recombinant enzyme.
    [Show full text]
  • K-RAS Gtpase- and B-RAF Kinase–Mediated T-Cell PNAS PLUS Tolerance Defects in Rheumatoid Arthritis
    K-RAS GTPase- and B-RAF kinase–mediated T-cell PNAS PLUS tolerance defects in rheumatoid arthritis Karnail Singha,1, Pratima Deshpandeb,1, Guangjin Lib, Mingcan Yub, Sergey Pryshchepa, Mary Cavanaghb, Cornelia M. Weyandb, and Jörg J. Goronzyb,2 aLowance Center for Human Immunology and Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322; and bDepartment of Medicine, Stanford University School of Medicine and Palo Alto Department of Veterans Affairs Health Care System, Palo Alto, CA 94304 Edited by Dennis A. Carson, University of California at San Diego, La Jolla, CA, and approved April 18, 2012 (received for review November 3, 2011) Autoantibodies to common autoantigens and neoantigens, such the signaling cascade after T-cell receptor (TCR) stimulation. as IgG Fc and citrullinated peptides, are immunological hallmarks Based on the substitution conferring increased phosphatase ac- of rheumatoid arthritis (RA). We examined whether a failure in tivity, it was originally considered a gain of function (12). Recent maintaining tolerance is mediated by defects in T-cell receptor findings, however, have shown that the variant is rapidly de- activation threshold settings. RA T cells responded to stimulation graded, causing T-cell hyperresponsiveness (13). The findings with significantly higher ERK phosphorylation (P < 0.001). Gene of disease-associated HLA-DRB1 alleles and PTPN22 poly- expression arrays of ERK pathway members suggested a higher morphisms indicate that T-cell recognition events and TCR expression of KRAS and BRAF, which was confirmed by quantita- threshold calibration are central to RA pathogenesis (13, 14). tive PCR (P = 0.003), Western blot, and flow cytometry (P < 0.01).
    [Show full text]
  • C-Terminal Proteolysis of Prenylated Proteins in Trypanosomatids And
    Molecular & Biochemical Parasitology 153 (2007) 115–124 C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins John R. Gillespie a, Kohei Yokoyama b,∗, Karen Lu a, Richard T. Eastman c, James G. Bollinger b,d, Wesley C. Van Voorhis a,c, Michael H. Gelb b,d, Frederick S. Buckner a,∗∗ a Department of Medicine, University of Washington, 1959 N.E. Pacific St., Seattle, WA 98195, USA b Department of Chemistry, University of Washington, Seattle, WA 98195, USA c Department of Pathobiology, University of Washington, Seattle, Washington 98195, USA d Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA Received 22 December 2006; received in revised form 17 February 2007; accepted 26 February 2007 Available online 1 March 2007 Abstract The C-terminal “CaaX”-motif-containing proteins usually undergo three sequential post-translational processing steps: (1) attachment of a prenyl group to the cysteine residue; (2) proteolytic removal of the last three amino acids “aaX”; (3) methyl esterification of the exposed ␣-carboxyl group of the prenyl-cysteine residue. The Trypanosoma brucei and Leishmania major Ras converting enzyme 1 (RCE1) orthologs of 302 and 285 amino acids-proteins, respectively, have only 13–20% sequence identity to those from other species but contain the critical residues for the activity found in other orthologs. The Trypanosoma brucei a-factor converting enzyme 1 (AFC1) ortholog consists of 427 amino acids with 29–33% sequence identity to those of other species and contains the consensus HExxH zinc-binding motif. The trypanosomatid RCE1 and AFC1 orthologs contain predicted transmembrane regions like other species.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • Geranylgeranylated Proteins Are Involved in the Regulation of Myeloma Cell Growth
    Vol. 11, 429–439, January 15, 2005 Clinical Cancer Research 429 Geranylgeranylated Proteins are Involved in the Regulation of Myeloma Cell Growth Niels W.C.J. van de Donk,1 Henk M. Lokhorst,3 INTRODUCTION 2 1 Evert H.J. Nijhuis, Marloes M.J. Kamphuis, and Multiple myeloma is characterized by the accumulation Andries C. Bloem1 of slowly proliferating monoclonal plasma cells in the bone Departments of 1Immunology, 2Pulmonary Diseases, and 3Hematology, marrow. Via the production of growth factors, such as University Medical Center Utrecht, Utrecht, the Netherlands interleukin-6 (IL-6) and insulin-like growth factor-I (1–4), and cellular interactions (5, 6), the local bone marrow microenvironment sustains tumor growth and increases the ABSTRACT resistance of tumor cells for apoptosis-inducing signals (7). Purpose: Prenylation is essential for membrane locali- Multiple signaling pathways are involved in the regulation of zation and participation of proteins in various signaling growth and survival of myeloma tumor cells. Activation of the pathways. This study examined the role of farnesylated and Janus-activated kinase-signal transducers and activators of geranylgeranylated proteins in the regulation of myeloma transcription (8), nuclear factor-nB (9–11), and phosphatidy- cell proliferation. linositol 3V-kinase (PI-3K; refs. 4, 12, 13) pathways has been Experimental Design: Antiproliferative and apoptotic implicated in the protection against apoptosis, whereas effects of various modulators of farnesylated and geranyl- activation of the PI-3K (4, 12, 13), nuclear factor-nB (10, 11), geranylated proteins were investigated in myeloma cells. and mitogen-activated protein kinase pathways (14) induces Results: Depletion of geranylgeranylpyrophosphate proliferation in myeloma cell lines.
    [Show full text]
  • Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
    cancers Review Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia Kalpana K. Bhanumathy 1,*, Amrutha Balagopal 1, Frederick S. Vizeacoumar 2 , Franco J. Vizeacoumar 1,3, Andrew Freywald 2 and Vincenzo Giambra 4,* 1 Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (A.B.); [email protected] (F.J.V.) 2 Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (F.S.V.); [email protected] (A.F.) 3 Cancer Research Department, Saskatchewan Cancer Agency, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada 4 Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, FG, Italy * Correspondence: [email protected] (K.K.B.); [email protected] (V.G.); Tel.: +1-(306)-716-7456 (K.K.B.); +39-0882-416574 (V.G.) Simple Summary: Protein phosphorylation is a key regulatory mechanism that controls a wide variety of cellular responses. This process is catalysed by the members of the protein kinase su- perfamily that are classified into two main families based on their ability to phosphorylate either tyrosine or serine and threonine residues in their substrates. Massive research efforts have been invested in dissecting the functions of tyrosine kinases, revealing their importance in the initiation and progression of human malignancies. Based on these investigations, numerous tyrosine kinase inhibitors have been included in clinical protocols and proved to be effective in targeted therapies for various haematological malignancies.
    [Show full text]
  • Formulas of Integration of Permissivity and of Directed Molecular Targeting in Oncogenesis
    Cancer Therapy & Oncology International Journal ISSN: 2473-554X Review Article Canc Therapy & Oncol Int J Volume 8 Issue 5 - January 2018 Copyright © All rights are reserved by Lawrence M Agius DOI: 10.19080/CTOIJ.2018.08.555749 Formulas of Integration of Permissivity and of Directed Molecular Targeting In Oncogenesis Lawrence M Agius* Department of pathology, University Of Malta Medical School, Malta, Submission: December 15, 2017; Published: January 05, 2018 *Correspondence Address: Lawrence M Agius, Department of pathology, University of Malta Medical School, Mater Dei Hospital Msida, TAL- QROQQ, Malta, Europe, Tel: ; Email: Abstract Dimensions of non-resolution or paradoxically of resolved integrative action allow for a dualized context of constitutive receptor activity and of permissiveness in the creation of the malignant phenotype of cancer cells. The proposition for such permissiveness is compounded by resolved end-result in oncogenesis that is projected in terms of aberrant over-activity of tyrosine kinases that include dimensions of over-activity in the face of non-resolved dynamics of spread and metastasis. It is within such dimensional context that the oncogenesis is portrayed as established pathways within a permissive context for further change progression. Growth factors and transcription factors allow for such permissiveness to integrate with the directed targeting of molecules in terms of protein-protein interactivity and tyrosine kinase formulations. Introduction formulation. Protein phosphorylation is strictly regulated by Intracellular and receptor tyrosine kinases constitute attractive targets for interfering with progression of in provision of activated/de-activated motif formulation is carcinogenesis. Strong evidence highlights the association protein kinases and protein phosphatases [4]. The significance further compounded by tyrosine kinase binding in the presence of autophagy with tyrosine kinase receptor signaling [1].
    [Show full text]
  • S41467-019-11729-1.Pdf
    ARTICLE https://doi.org/10.1038/s41467-019-11729-1 OPEN Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer Qingfei Wang1,2, Ian H. Guldner1,2, Samantha M. Golomb1,2, Longhua Sun1,2, Jack A. Harris1,2, Xin Lu1,2,3 & Siyuan Zhang 1,2,3 fi 1234567890():,; Acquired resistance to targeted cancer therapy is a signi cant clinical challenge. In parallel with clinical trials combining CDK4/6 inhibitors to treat HER2+ breast cancer, we sought to prospectively model tumor evolution in response to this regimen in vivo and identify a clinically actionable strategy to combat drug resistance. Despite a promising initial response, acquired resistance emerges rapidly to the combination of anti-HER2/neu antibody and CDK4/6 inhibitor Palbociclib. Using high-throughput single-cell profiling over the course of treatments, we reveal a distinct immunosuppressive immature myeloid cell (IMC) population to infiltrate the resistant tumors. Guided by single-cell transcriptome analysis, we demon- strate that combination of IMC-targeting tyrosine kinase inhibitor cabozantinib and immune checkpoint blockade enhances anti-tumor immunity, and overcomes the resistance. Fur- thermore, sequential combinatorial immunotherapy enables a sustained control of the fast- evolving CDK4/6 inhibitor-resistant tumors. Our study demonstrates a translational frame- work for treating rapidly evolving tumors through preclinical modeling and single-cell analyses. 1 Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, IN 46556, USA. 2 Mike and Josie Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA. 3 The Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA.
    [Show full text]
  • The Protein Lipidation and Its Analysis
    Triola, J Glycom Lipidom 2011, S:2 DOI: 10.4172/2153-0637.S2-001 Journal of Glycomics & Lipidomics Research Article Open Access The Protein Lipidation and its Analysis Gemma Triola Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany Abstract Protein Lipidation is essential not only for membrane binding but also for the interaction with effectors and the regulation of signaling processes, thereby playing a key role in controlling protein localization and function. Cholesterylation, the attachment of the glycosylphosphatidylinositol anchor, as well as N-myristoylation, S-prenylation and S-acylation are among the most relevant protein lipidation processes. Little is still known about the significance of the high diversity in lipid modifications as well as the mechanism by which lipidation controls function and activity of the proteins. Although the development of new strategies to uncover these and other unexplored topics is in great demand, important advances have already been achieved during the last years in the analysis of protein lipidation. This review will highlight the most prominent lipid modifications encountered in proteins and will provide an overview of the existing methods for the analysis and identification of lipid modified proteins. Introduction new tools and strategies. As such, this review will highlight the most prominent lipid modifications encountered in proteins and will provide Biological cell membranes are typically formed by mixtures an overview of the existing methods for the analysis and identification of lipids and proteins. Whereas the major lipid components are of lipid modified proteins detailing their advantages and limitations. glycerophospholipids, cholesterol and sphingolipids, proteins located in the membrane can be divided in two main classes, integral proteins Types of Lipidation and associated proteins.
    [Show full text]